Rapid Group A Streptococcus Test Kit Supply

The contract seeks the supply of FDA-cleared rapid diagnostic test kits designed to detect Group A Streptococcal antigen from both throat swabs and cultured colonies, with full compliance required for packaging, labeling, and all associated regulatory documentation. The kits must meet stringent quality and regulatory standards to ensure accuracy, reliability, and compliance with U.S. health and safety regulations, and must be ready for immediate deployment in clinical or field settings. This is a subcontract under the Department of Defense’s Medical Supply Chain division, with performance required at FPO, zip code 09567, and responses are due by July 27, 2026, following a posting date of July 20, 2026. The NAICS code 325213 identifies the industry as pharmaceutical and medicine manufacturing, indicating the supplier must have proven expertise in diagnostic product development and regulatory compliance.